Abstract
The aim of this article is to review the literature on steroid 5alpha-reductase type 2 deficiency (5α-RD2) to provide clinicians with information to guide their management of patients with this disorder. The 5alpha-reductase type 2 is encoded by the 5alpha-reductase type 2 gene (SRD5A2) on chromosome 2 and is predominantly expressed in external genital tissues and the prostate. Mutations of the SRD5A2 gene leads to an uncommon autosomal recessive disorder affecting sexual differentiation in individuals with 46,XY karyotype; their phenotype can range from almost normal female structures to a distinct male phenotype with ambiguous genitalia at birth. These phenotypes result from impaired conversion of testosterone to dihydrotestosterone due to mutations in the SRD5A2 gene. Patients exhibit virilization at puberty without breast development, which is often accompanied by gender identity change from female to male. More than 40 mutations have been reported in all five exons of the SRD5A2 gene. Phenotype–genotype correlations for 5α-RD2 have not been well established. The newborn phenotypes of male pseudohermaphrodites with 5α-RD2, partial androgen insensitivity syndrome (PAIS), or 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) enzyme deficiency may be indistinguishable. We conclude that steroid 5α-RD2 should be included in the differential diagnosis of newborns with 46,XY DSD. It is important that the diagnosis be made in infancy by biochemical and molecular studies before gender assignment or any surgical intervention because these patients should be considered males at birth.
This is a preview of subscription content, access via your institution.



Abbreviations
- ACTH:
-
adrenocorticotropic hormone
- AIS:
-
androgen insensitivity syndrome
- PAIS:
-
partial androgen insensitivity syndrome
- AR:
-
androgen receptor
- DHT:
-
dihydrotestosterone
- DSD:
-
disorders of sex development
- AT:
-
androstenedione
- T:
-
testosterone
- 17β-HSD3:
-
17β-hydroxysteroid dehydrogenase type 3
- SRD5A2:
-
steroid 5alpha-reductase type 2 gene
- 5α-RD2:
-
5alpha-reductase type 2 deficiency
- hCG:
-
human chorionic gonadotropin
- SRY:
-
sex-determining region of the Y chromosome
- AMH:
-
anti-Müllerian hormone
- FSH:
-
follicle-stimulating hormone
- LH:
-
luteinizing hormone
- MRI:
-
magnetic resonance imaging
- WT-1:
-
Wilms’ tumor-1
- SF-1:
-
steroidogenic factor 1
References
Alias AG (2004) A role for 5alpha-reductase activity in the development of male homosexuality? Ann N Y Acad Sci 1032:237–244
Allen L (2009) Disorders of sexual development. Obstet Gynecol Clin North Am 36:25–45
Bahceci M, Ersay AR, Tuzcu A et al (2005) A novel missense mutation of 5-alpha reductase type 2 gene (SRD5A2) leads to severe male pseudohermaphroditism in a Turkish family. Urology 66:407–410
Bentz EK, Schneeberger C, Hefler LA et al (2007) A common polymorphism of the SRD5A2 gene and transsexualism. Reprod Sci 14:705–709
Bertelloni S, Dati E, Baroncelli GI (2008) Disorders of sex development: hormonal management in adolescence. Gynecol Endocrinol 24:339–346
Bertelloni S, Scaramuzzo RT, Parrini D et al (2007) Early diagnosis of 5alpha-reductase deficiency in newborns. Sex Dev 1:147–151
Byne W (2006) Developmental endocrine influences on gender identity: implications for management of disorders of sex development. Mt Sinai J Med 73:950–959
Canto P, Vilchis F, Chavez B et al (1997) Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase -2 deficiency. Clin Endocrinol 46:155–160
Carrillo AA, Damian M, Berkovitz G (2007) Disorders of sexual differentiation. In: Lifshitz F (ed) Pediatric endocrinology, 5th edn. Marcel Dekker, New York, pp 365–390
Chan AO, But BW, Lau GT et al (2009) Diagnosis of 5 alpha-reductase 2 deficiency: a local experience. Hong Kong Med J 15:130–135
Chávez B, Valdez E, Vilchis F (2000) Uniparental disomy in steroid 5alpha-reductase 2 deficiency. J Clin Endocrinol Metab 85:3147–3150
Chavhan GB, Parra DA, Oudjhane K et al (2008) Imaging of ambiguous genitalia: classification and diagnostic approach. Radiographics 28:1891–1904
Choi JH, Kim GH, Seo EJ et al (2008) Molecular analysis of the AR and SRD5A2 genes in patients with 46, XY disorders of sex development. J Pediatr Endocrinol Metab 21:545–553
Cohen-Kettenis PT (2005) Gender change in 46, XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 34:399–410
Committee on Genetics, Section on Endocrinology and Section on Urology (2000) Evaluation of the newborn with developmental anomalies of the external genitalia. Pediatrics 106:138–142
Guerra-Júnior G, Maciel-Guerra AT (2007) The role of the pediatrician in the management of children with genital ambiguities. J Pediatr (Rio J) 83:184–191
Hannema SE, Hughes IA (2007) Regulation of Wolffian duct development. Horm Res 67:142–151
Hiort O, Willenbring H, Albers N et al (1996) Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency. Eur J Pediatr 155:445–451
Houk CP, Hughes IA, Ahmed SF et al (2006) Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference. Pediatrics 118:753–757
Hrabovsky Z, Huston JM (2002) Androgen imprinting of the brain in animal models and humans with intersex disorders: review and recommendations. J Urol 168:2142–2148
Hughes IA, Houk C, Ahmed SF et al (2006) Consensus statement on management of intersex disorders. J Pediatr Urol 2:148–162
Imperato-McGinley J, Zhu YS (2002) Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 30(198):51–59
Kim SH, Kim KS, Kim GH et al (2006) A novel frameshift mutation in the 5alpha-reductase type 2 gene in Korean sisters with male pseudohermaphroditism. Fertil Steril 85:e9–e12
Kojima Y, Mizuno K, Nakane A et al (2009) Long-term physical, hormonal, and sexual outcome of males with disorders of sex development. J Pediatr Surg 44:1491–1496
Kulkarni KP, Panigrahi I, Das R et al (2009) Pediatric disorders of sex development. Indian J Pediatr 76:956–958
Mazen I, Gad YZ, Hafez M et al (2003) Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation. Clin Endocrinol (Oxf) 58:627–631
Mendonca BB, Domenice S, Arnhold IJ et al (2009) 46, XY disorders of sex development (DSD). Clin Endocrinol (Oxf) 70:173–187
Mieszczak J, Houk CP, Lee PA (2009) Assignment of the sex of rearing in the neonate with a disorder of sex development. Curr Opin Pediatr 21:541–547
Mowszowicz I, Berthauit I, Mestayer C et al (1995) 5-alpha-reductases: physiology and pathology. Ann Endocrinol (Paris) 56:555–559
Nicoletti A, Baldazzi L, Balsamo A et al (2005) SRD5A2 gene analysis in an Italian population of under-masculinized 46, XY subjects. Clin Endocrinol (Oxf) 63:375–380
Nimkarn S, Likitmaskul S, Sangacharoenkit P et al (2002) Ambiguous genitalia: an overview of 22 years experience and the diagnostic approach in the Pediatric Department, Siriraj Hospital. J Med Assoc Thai 85(supple 2):496–505
Nordenskjöld A, Ivarsson SA (1998) Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab 83:3236–3238
Nordenskjöld A, Magnus O, Aagenaes O et al (1998) Homozygous mutation (A228T) in the 5alpha-reductase type 2 gene in a boy with 5alpha-reductase deficiency: genotype-phenotype correlations. Am J Med Genet 16(80):269–272
Parisi MA, Ramsdell LA, Burns MW et al (2007) A Gender Assessment Team: experience with 250 patients over a period of 25 years. Genet Med 9:348–357
Sahakitrungruang T, Wacharasindhu S, Yeetong P et al (2008) Identification of mutations in the SRD5A2 gene in Thai patients with male pseudohermaphroditism. Fertil Steril 90:e11–e15
Sahu R, Boddula R, Sharma P et al (2009) Genetic analysis of the SRD5A2 gene in Indian patients with 5alpha-reductase deficiency. J Pediatr Endocrinol Metab 22:247–254
Sasaki G, Nakagawa K, Hashiguchi A et al (2003) Giant seminoma in a patient with 5 alpha-reductase type 2 deficiency. J Urol 169:1080–1081
Sinnecker GH, Hiort O, Dibbelt L et al (1996) Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 63:223–230
Sultan C, Paris F, Terouanne B et al (2001) Disorders linked to insufficient androgen action in male children. Hum Reprod Update 7:314–322
Thigpen AE, Davis DL, Milatovich A et al (1992) Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 90:799–809
Vilain E, Sarafoglou K, Yehya N (2009) Disorders of sex development. In: Sarafoglou K, Hoffmann GF, Roth KS (eds) Pediatric endocrinology and inborn errors of metabolism. McGraw-Hill, New York, pp 545–546
Vilchis F, Valdez E, Ramos L et al (2008) Novel compound heterozygous mutations in the SRD5A2 gene from 46, XY infants with ambiguous external genitalia. J Hum Genet 53:401–406
Warne GL, Raza J (2008) Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord 9:227–236
Witchel SF, Lee PA (2002) Ambiguous genitalia. In: Sperling MA (ed) Pediatric endocrinology, 3rd edn. Saunders, Philadelphia, pp 127–164
Conflict of interest
The authors certify that they have no relationship with the organizations that sponsored the research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheon, C.K. Practical approach to steroid 5alpha-reductase type 2 deficiency. Eur J Pediatr 170, 1–8 (2011). https://doi.org/10.1007/s00431-010-1189-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-010-1189-4
Keywords
- 5alpha-reductase type 2 deficiency
- Ambiguous genitalia
- Gender identity
- SRD5A2